Tectonic Therapeutic, Inc.
TECX
$27.96
$0.441.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.20% | 7.03% | -6.71% | 18.40% | 144.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.20% | 53.78% | 11.47% | 95.53% | 41.10% |
| Operating Income | -49.20% | -53.78% | -11.47% | -95.53% | -41.10% |
| Income Before Tax | -58.69% | -53.33% | -7.44% | -50.01% | -4.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.69% | -55.39% | -7.44% | -57.71% | -4.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.69% | -55.39% | -7.44% | -57.71% | -4.50% |
| EBIT | -49.20% | -53.78% | -11.47% | -95.53% | -41.10% |
| EBITDA | -50.50% | -57.11% | -12.15% | -98.39% | -42.47% |
| EPS Basic | -45.07% | -22.80% | 15.44% | 75.35% | 91.55% |
| Normalized Basic EPS | -45.06% | -21.17% | 15.43% | 76.55% | 91.55% |
| EPS Diluted | -45.07% | -22.80% | 15.44% | 75.35% | 91.55% |
| Normalized Diluted EPS | -45.06% | -21.17% | 15.43% | 76.55% | 91.55% |
| Average Basic Shares Outstanding | 9.39% | 26.54% | 27.05% | 539.75% | 1,136.77% |
| Average Diluted Shares Outstanding | 9.39% | 26.54% | 27.05% | 539.75% | 1,136.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |